Alexion acquisition to be examined by U.K. regulators

British regulatory authorities have opened an inquiry into AstraZeneca’s proposed $39 billion acquisition of Boston’s Alexion Pharmaceuticals Inc. (Nasdaq: ALXN), on the basis that the transaction could negatively affect competition. Read More

Read More

Two software companies, eyeing IPOs, hire new finance execs

In separate announcements, enterprise AI unicorn DataRobot Inc. and cloud security company iboss Inc. said they added finance executives to their teams. In both cases, the new executives have public-company expertise, and their respective CEOs have recently shared with the Business Journal their future plans to hit the public markets. Read More

Read More

Bain plans new fund for life sciences real estate

The private equity giant’s real estate team has worked on two funds with broad investment mandates since coming aboard in 2018. Now, it’s targeting an asset class that has grown more attractive to investors during the pandemic. Read More

Read More

Boston AI company Affectiva to be acquired for $73.5M

Affectiva’s acquisition comes shortly after several Massachusetts tech businesses announced merger and acquisition deals. This year, online liquor store Drizly Inc., speech recognition firm Nuance Communications Inc. (Nasdaq: NUAN) and sales tax management system TaxJar Inc. were acquired by, respectively, Uber Technologies Inc. (NYSE: UBER), Microsoft Corp. (Nasdaq: MSFT) and Stripe Inc. Read More

Read More